China News Service, March 12, according to "Central News Agency", recently, many European countries temporarily stopped the British AstraZeneca vaccine due to thrombosis among vaccinators.
In response, the European Medicines Agency (EMA) issued an emergency statement hoping to dispel public doubts, stating that "there are currently no known related health risks."
According to reports, Denmark, Norway and Iceland announced earlier on the 11th that they would temporarily discontinue the new crown vaccine jointly developed by AstraZeneca and the University of Oxford, worrying that vaccination may be related to the occurrence of thrombosis.
At the same time, Italy and Austria have also stopped some batches of AstraZeneca vaccine for prevention.
The Italian Pharmaceutical Agency said in a statement on the 11th that due to the recent reports of severe side effects in Italy and other European countries, it has decided to suspend a batch of AstraZeneca's new crown vaccine in Italy.
Earlier in Austria, a woman died of severe coagulation dysfunction after being vaccinated with AstraZeneca.
Austria subsequently suspended this batch of vaccination.
On December 27, 2020, many member states of the European Union officially launched the new crown vaccination work.
The picture shows Belgian medical staff preparing for the new crown vaccination work.
According to reports, the suspension of vaccines in Italy and Austria involves different batches.
Romania stated that it has temporarily suspended the same batch of suspicious vaccines as Italy, but will continue to use other batches of AstraZeneca vaccine; Estonia, Latvia, Lithuania and Luxembourg have suspended the same batches of vaccines as Austria AstraZeneca vaccine.
In response, the European Medicines Agency stated that as of March 10, among the 5 million people in Europe who had been vaccinated with AstraZeneca, there were 30 cases of thrombosis.
The European Medicines Agency said: “There is currently no indication that vaccination has caused these conditions, and these conditions are not listed as side effects of this vaccine.” The agency also said, “This vaccine still has more advantages than disadvantages. While continuing to investigate cases of thrombotic events, it is still possible to continue to administer this vaccine."
At the same time, the United Kingdom called the AstraZeneca vaccine "safe and effective"; the French Minister of Health also said that there is no need to stop it at this time.